Product NewsDrug discovery > Pre-Clinical Development
Comparing immune humanized platforms: Which one is best for my application?
6 Feb 2024
In this video, Dr. Brian Soper from The Jackson Laboratory discusses immune-humanized platforms, which enable researchers to test a wide range of human-specific therapeutic approaches developed to either up or down regulate immune function. Dr. Soper explores the differences in immune engraftment based on the type of cells implanted and the host supporting those populations.
About the company
The Jackson Laboratory
The Jackson Laboratory is a global leader in preclinical studies and has been driving therapeutic development breakthroughs for over 90 years. With the most innovative preclinical platforms including humanized mice, and services such as dose ranging, toxicity, and efficacy studies, JAX empowers drug developers and researchers worldwide.
